USFDA completes inspection at Laurus Labs’ API manufacturing facilities

19 Apr 2024 Evaluate

United States Food & Drug Administration (USFDA) has completed inspection at Laurus Labs’ API manufacturing facilities Unit-1 and Unit-3, Parawada, Anakapalli (Visakhapatnam), Andhra Pradesh. The inspection was conducted from April 15, 2024 to April 19, 2024. The inspection was successfully closed without any 483 observations.

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.

Laurus Labs Share Price

570.80 3.65 (0.64%)
26-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1841.50
Dr. Reddys Lab 1355.15
Cipla 1489.20
Lupin 2181.60
Zydus Lifesciences 959.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.